US WorldMeds, LLC Receives $15 Million Grant to Launch New Study
6/18/2013 9:37:54 AM
More...
|
US WorldMeds, LLC Release: New Clinical Trial Investigates APOKYN for Treating Debilitating Morning Akinesia in Parkinson’s Disease Patients
5/13/2013 9:58:07 AM
More...
|
US WorldMeds, LLC Acquires Solstice Neurosciences, Inc. For $35.7 Million
8/13/2010 8:44:17 AM
More...
|
US WorldMeds, LLC Announces the Launch of Revonto(TM) (Dantrolene Sodium for Injection)
7/7/2010 11:30:53 AM
More...
|
US WorldMeds, LLC Completes Phase III Trial of Lofexidine for Treatment of Opiate Withdrawal Symptoms
6/16/2008 9:21:08 AM
More...
|
US WorldMeds, LLC Completes Development of Instantaneous Reconstitution Dantrolene Sodium for Injection Product
5/8/2008 9:56:17 AM
More...
|
FDA Initiates Phase III Trial Of Lofexidine For Treatment Of Opiate Withdrawal Symptoms
10/9/2006 12:20:11 PM
More...
|
Britannia Pharmaceuticals Limited Signs Agreement With US WorldMeds, LLC To Bring First Non-Opiate Drug Addiction Treatment To The U.S.
10/19/2005 5:10:48 PM
More...
|